Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
|
|
ARRAY BIOPHARMA INC (ARRY)
|
Add to portfolio |
|
|
|
| Price: |
$14.97
| | Metrics |
| OS: |
221.8
|
M
| |
-41
|
% ROE
|
| Market cap: |
$3.32
|
B
| |
-34
|
% ROIC
|
|
Net cash:
|
$345
|
M
| |
$1.56
|
per share
|
|
EV:
|
$2.97
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($130)
|
M
| |
|
|
|
EBIT
|
($132)
|
M
| |
|
|
| EPS |
($0.58)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
| Date Filed | Type | Description |
| 04/26/2021 |
GN
| Array Technologies Secures Contract for up to 4GW of Trackers |
| 03/23/2021 |
GN
| Array Technologies, Inc. Announces Closing of Secondary Offering of 35,475,457 Shares |
| 03/18/2021 |
GN
| Array Technologies, Inc. Announces Pricing of Secondary Offering of 31,054,971 Shares |
| 03/16/2021 |
GN
| Array Technologies, Inc. Announces Launch of Secondary Offering of 31,054,971 Shares |
| 03/09/2021 |
GN
| Array Technologies, Inc. Reports Financial Results for the Fourth Quarter and Full Year 2020 |
| 02/19/2021 |
GN
| Array Technologies, Inc. Announces Fourth Quarter & Full-Year 2020 Earnings Release Date and Conference Call |
| 12/07/2020 |
GN
| Array Technologies, Inc. Announces Closing of Secondary Offering of 36,656,250 Shares |
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Jun-30-18 | Jun-30-17 | Jun-30-16 | Jun-30-15 | Jun-30-14 | Jun-30-13 | Jun-30-12 | Jun-30-11 |
| Revenues | 173.8 | 150.9 | 137.9 | 51.9 | 42.1 | 69.6 | 85.1 | 71.9 |
| Revenue growth | 15.2% | 9.4% | 165.6% | 23.4% | -39.5% | -18.3% | 18.4% | 33.4% |
| Cost of goods sold | 59.4 | 35.4 | 23.2 | 44.4 | 46.0 | 30.1 | 24.3 | 28.9 |
| Gross profit | 114.4 | 115.5 | 114.7 | 7.5 | -3.9 | 39.5 | 60.9 | 43.0 |
| Gross margin | 65.8% | 76.5% | 83.2% | 14.5% | -9.2% | 56.8% | 71.5% | 59.8% |
| Selling, general and administrative | | | | | | | | |
| Research and development | 185.8 | 178.2 | 160.7 | 54.4 | 49.8 | 59.4 | 56.7 | 63.5 |
| General and administrative | 58.5 | 39.3 | 36.3 | 31.4 | 21.9 | 19.6 | 15.2 | 16.3 |
| EBIT | -126.6 | -99.5 | -82.2 | 3.3 | -75.6 | -39.5 | -11.0 | -36.8 |
| EBIT margin | -72.9% | -65.9% | -59.6% | 6.3% | -179.7% | -56.8% | -13.0% | -51.1% |
| Pre-tax income | -142.7 | -116.8 | -92.8 | 9.4 | -85.3 | -61.9 | -23.6 | -56.3 |
| Income taxes | 2.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -145.0 | -116.8 | -92.8 | 9.4 | -85.3 | -61.9 | -23.6 | -56.3 |
| Net margin | -83.5% | -77.4% | -67.3% | 18.1% | -202.6% | -89.0% | -27.7% | -78.3% |
| |
| Diluted EPS | ($0.73) | ($0.72) | ($0.65) | $0.07 | ($0.69) | ($0.57) | ($0.33) | ($1.02) |
| Shares outstanding (diluted) | 198.5 | 163.2 | 143.0 | 141.7 | 123.4 | 107.8 | 70.6 | 55.4 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|